The AHA today responded to a Department of Health and Human Services request for input from health care providers and other stakeholders on ensuring legitimate access to controlled substances, including opioids, while preventing diversion and abuse. The Ensuring Patient Access and Effective Drug Enforcement Act of 2016 calls for HHS’ Office of the Assistant Secretary for Planning and Evaluation to submit a report to Congress on the issue. Among other actions, AHA recommends providing additional support for medical education, training and guidance for non-opioid pain management as well as for state drug courts, which offer justice-involved individuals with substance use disorders the opportunity to enter treatment programs.

Related News Articles

Headline
The Senate Health, Education, Labor and Pensions Committee yesterday voted 12-11 along party lines to recommend the confirmation of Brian Christine, M.D., to…
Chairperson's File
Public
This month Congress enacted the One Big Beautiful Bill Act — a sweeping package that contained many of President Trump’s legislative priorities on taxes,…
Headline
The Centers for Medicare & Medicaid Services July 15 issued a proposed rule that would increase Medicare hospital outpatient prospective payment system…
Headline
The AHA July 2 expressed support for the Resident Physician Shortage Reduction Act (H.R. 3890), bipartisan legislation that would add 14,000 Medicare-funded…
Headline
The House July 3 voted 218-214 to pass the final version of the One Big Beautiful Bill Act (H.R. 1), which enacts many of President Trump’s legislative…
Headline
The House has begun consideration of the Senate-passed version of the One Big Beautiful Bill Act (H.R. 1). This continues to be a fluid…